ArticleMethods in molecular biology (Clifton, N.J.)2026
Preparation of the Low Molecular Weight Serum Proteome for Mass Spectrometry Analysis.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The ability to cure or manage devastating diseases such as cancer and dementia is highly dependent on their molecular diagnosis at the earliest time point possible. Recent technological developments have spurred the search for circulating protein biomarkers of various diseases; however, serum and plasma are extremely challenging samples owing to the wide dynamic range of protein concentration. Fractionating these samples into simpler aliquots has proven to be an effective strategy in identifying lower abundant proteins within these samples, which are believed to be the regiment where biomarkers exist. This article describes a method that fractionates serum to isolate low molecular weight proteins. By isolating this fraction, many of the abundant, higher molecular proteins such as albumin and immunoglobulins are eliminated making the identification of lower abundant proteins in serum possible.
Indexed as
Identifiers
41085629What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.